Navigation Links
Researchers at Sarasota Memorial Health Care System to study airway bypass treatment for emphysema
Date:12/17/2007

Sarasota FL., December 17, 2007 Researchers at Sarasota Memorial Health Care System today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new, minimally-invasive option for those suffering with advanced widespread emphysema. The study focuses on a procedure called airway bypass that involves creating pathways in the lung for trapped air to escape and in turn, relieve emphysema symptoms including shortness of breath.

Emphysema is a chronic, progressive, and irreversible lung disease characterized by the destruction of lung tissue. The loss of the lungs' natural elasticity and the collapse of airways in the lung combine to make exhalation ineffective, leaving the emphysema sufferer with hyperinflation because they cant get air out of their lungs. With hyperinflation, breathing becomes inefficient and the patient is always short of breath. Even the most nominal physical activities become difficult for emphysema patients and many become dependent on oxygen therapy.

We are excited to be part of this study because currently treatment options for the emphysema patients are very limited and many patients have a very poor quality of life, states Kirk Voelker, MD, principal investigator of the study at Sarasota Memorial Hospital. By creating new pathways for airflow with the airway bypass procedure, we hope to reduce hyperinflation and improve lung function. If patients can breathe easier it is likely to improve their quality of life.

During airway bypass, physicians will use a flexible bronchoscope to go through the mouth into the airways. There the physician will create new small pathways and place an Exhale Drug-Eluting Stent manufactured by Broncus Technologies, Inc. - to allow the trapped air in the lung to escape. Patients could see an immediate improvement in dyspnea (shortness of breath).<
'/>"/>

Contact: Meghan Oreste
moreste@comcast.net
617-823-1441
Broncus Technologies  
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers identify proteins involved in new neurodegenerative syndrome
2. Texas researchers and educators head for Antarctica
3. MGH researchers describe new way to identify, evolve novel enzymes
4. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
5. U of MN researchers discover noninvasive diagnostic tool for brain diseases
6. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
7. Researchers discover new strategies for antibiotic resistance
8. Researchers find new taste in fruit flies: carbonated water
9. Binghamton University researchers investigate evolving malaria resistance
10. UIC researchers find promising new targets for antibiotics
11. Researchers develop simple method to create natural drug products
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers at Sarasota Memorial Health Care System to study airway bypass treatment for emphysema
Researchers at Sarasota Memorial Health Care System to study airway bypass treatment for emphysema
(Date:10/9/2008)...er the past twenty-five years, the number of patie...onomically. High-risk patients such as these requi...into consideration everything from the etiology an...atient,s nutritional status. A new text from ASM P...ised Host,examines a wide range of approaches an...
(Date:10/9/2008)...e National Institute of Allergy and Infectious Dis...Health (NIH), will award five-year contracts estim...ms in Systems Biology for Infectious Disease Resea...ach facility will apply novel techniques to study ...drome (SARS), tuberculosis and influenza. , Syst...
(Date:10/9/2008)... WASHINGTON, Oct. 9 -- Medical research is a corne... Annual Meeting of the Optical Society (OSA), bein...er in Rochester, N.Y. FiO 2008 will take place al...the American Physical Society,s Division of Laser ...adge to attend the meeting should contact Colleen ...
(Date:10/9/2008)...rth Carolina State University researchers are laun... crime scene investigation training throughout the...g to law enforcement personnel and forensic scient...t of nationwide standards for death investigations...n H. Ross, has received a grant from the U.S. Depa...
Breaking Biology News(10 mins):Text focuses on diagnosing infections in immunocompromised patients 2New Systems Biology Awards enable detailed study of microbes 2Where optics meets medicine 2Where optics meets medicine 3Where optics meets medicine 4Where optics meets medicine 5Where optics meets medicine 6Where optics meets medicine 7NC State takes lead in crime scene investigation training 2Internationally Acclaimed Music and Medicine Program Comes to Chaska 17417 1Internationally Acclaimed Music and Medicine Program Comes to Chaska 17417 2IMPAC Medical Systems Announces 2008 Laboratory Professionals of the Year 4772 1IMPAC Medical Systems Announces 2008 Laboratory Professionals of the Year 4772 2IMPAC Medical Systems Announces 2008 Laboratory Professionals of the Year 4772 3Quest PharmaTech Receives Support from National Research Councils Industrial Research Assistance Program 28NRC IRAP 29 to develop Ultrasound Technolo 4770 1Quest PharmaTech Receives Support from National Research Councils Industrial Research Assistance Program 28NRC IRAP 29 to develop Ultrasound Technolo 4770 2Melanoma lurks in larger skin lesions NYU researchers find 17416 1Melanoma lurks in larger skin lesions NYU researchers find 17416 2
...that restoring a gene often silenced in lung cance...could lead to a new strategy for treating the dise...OX, which is lost or silenced in a large majority ...ry, prostate, bladder, esophagus and pancreas. The...ersity Comprehensive Cancer Center ? Arthur G. Jam...
...opean Molecular Biology Laboratory (EMBL) in Heid... the Parc Cient?fic de Barcelona (IRB-PCB) have no...cancer originate with defects in stem cells. The s... Nature Genetics (September 4) shows that if key...thin stem cells before they divide, the result can...
... of researchers has discovered that human embryoni...tic material over time. , The findings do not lim...arch or for some future clinical applications, the...o closely monitor stem cell lines for genetic chan...cells, behavior. The researchers, work is describe...
...HIV-infected patients in India has risen in respon...l therapy (ART), according to an article in the No...vailable online. The introduction of generic drugs...V treatment because of the cheaper cost, the artic...nfected people living in India have been unable to...
Other Biology News:Restoring silenced suppressor gene kills lung-cancer cells 2A new link between stem cells and tumors 2Embryonic stem cells accrue genetic changes 2Embryonic stem cells accrue genetic changes 3Embryonic stem cells accrue genetic changes 4HIV mortality in India drops with introduction of generic antiretroviral therapy 2
(Date:10/10/2008)...LLE, Md., Oct. 10 /- EntreM...eutical company developing,therapeutics for the tr...nced today that Thomas H. Bliss, Jr., EntreMed,s S...opment, will present a Company,overview at the 16t... being,held October 12-14, 2008 in London, United ...
(Date:10/9/2008)...K RIDGE, Oct. 9, 2008 -- New analytical tools comi...epartment of Energy,s state-of-the-art neutron sci...clude a beam line dedicated to nuclear physics stu...e (FNPB) has opened its shutter to receive neutron...udies planned for the new, intense beam line are e...
(Date:10/9/2008)...Number 7 out of top 20 Employers Across Life Scien...re/ -- EMD Serono, Inc., an affiliate,of Merck KGa... been named,by Science magazine as a top employer ..., ranking number 7 out of the top 20 employers,acr...scientific community has recognized EMD Serono,as ...
(Date:10/9/2008)...ELPHIA, Oct. 9 /- eResearch...g provider of centralized ECG and,eClinical techno...l,biotechnology, medical device, and related indu...008 third quarter results for the period ended,Sep...r the market closes.,After the release, the Compan...
Breaking Biology Technology:EntreMed to Present at BioPartnering Europe Conference 2EntreMed to Present at BioPartnering Europe Conference 3Spallation Neutron Source sends first neutrons to 'Big Bang' beam line 2EMD Serono Named as a Top Employer by Science Magazine 2eResearchTechnology, Inc. to Announce 2008 Third Quarter Results on October 30, 2008 2
...d start-up that is leading the blog tools market s...t-up legend. , ,The two founders - husband-and-wif...eethearts. They got way into Web publishing and cr...dely used blogging platform. In 2002, they formed ...of days between their birth dates. Initially, they...
...tribution, Inc. , a high-tech distribution and pro...y owned subsidiary of Video Without Boundaries, I...ve, media-convergent home entertainment devices, a...rchase GDI. The deal will provide warehousing, dis...r VWBs consumer electronics products, including it...
...f the Madison and Dane County directory of high-te...as & Electric. Sponsored by MG&E and the City of M...eater Madison, Wisconsin, Area Directory of High-T... listings and variety of resources for regional bu...ment manager, who coordinates the directory, said ...
...nathan Watson will become the first student to gra...s physics and engineering dual degree program . , ...helors degree in physics from UW-Eau Claire and hi...ity of Minnesota. , ,The dual degree program was a...se work because I began with experience in areas s...
Other Biology Technology:Six Apart hits its adolescence 2Six Apart hits its adolescence 3Six Apart hits its adolescence 4Six Apart hits its adolescence 5Dane Country high-tech businesses continue to flourish 2Dane Country high-tech businesses continue to flourish 3Student to graduate in the Dual Degree Physics and Engineering Program 2
SCCRO (S-17)
S-Protein Agarose from Novagen
Blasticidin is a nucleoside antibiotic from Streptomyces griseochromogenes. It is a potent translational inhibitor in both prokaryotic and eukaryotic cells. Resistance to blasticidin is conferred by
15(S)-15-methyl PGF2α is a metabolically stable analog of PGF2α. It is a potent uterine stimulant and abortifacient which can be administered intramuscularly to induce labor. It induces
Biology Products: